We are live on ! Find out more
RFM

Royal Fund Management Portfolio holdings

AUM $1.2B
1-Year Est. Return 32.21%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+32.21%
3 Year Est. Return
+92.42%
5 Year Est. Return
+97.01%
10 Year Est. Return
AUM
$279M
AUM Growth
+$27.7M
Cap. Flow
+$13.4M
Cap. Flow %
4.79%
Top 10 Hldgs %
34.45%
Holding
719
New
225
Increased
172
Reduced
75
Closed
44

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.79M
2
GSK icon
GSK
GSK
+$3.54M
3
PPL
PPL Corp
PPL
+$2.33M
4
T icon
AT&T
T
+$968K
5
DEO icon
Diageo
DEO
+$538K

Sector Composition

Rank Sector Weight
1 Consumer Staples 15.3%
2 Technology 14.94%
3 Energy 10.16%
4 Consumer Discretionary 9.72%
5 Healthcare 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGIH icon
426
LGI Homes
LGIH
$1.27B
$7K ﹤0.01%
+102
New +$6.48K
MTZ icon
427
MasTec
MTZ
$21.1B
$7K ﹤0.01%
+161
New +$7.18K
ORCL icon
428
Oracle
ORCL
$374B
$7K ﹤0.01%
158
+54
+52% +$2.65K
SCHW
429
Charles Schwab
SCHW
$183B
$7K ﹤0.01%
+138
New +$6.48K
SIG icon
430
Signet Jewelers
SIG
$3.61B
$7K ﹤0.01%
+137
New +$8.37K
VGM icon
431
Invesco Trust Investment Grade Municipals
VGM
$548M
$7K ﹤0.01%
+554
New +$7.33K
VGT icon
432
Vanguard Information Technology ETF
VGT
$139B
$7K ﹤0.01%
352
-144
-29% -$2.92K
WNC icon
433
Wabash National
WNC
$512M
$7K ﹤0.01%
+361
New +$7.52K
SGI
434
Somnigroup International
SGI
$13.7B
$7K ﹤0.01%
+500
New +$7.63K
VRTU
435
DELISTED
Virtusa Corporation
VRTU
$7K ﹤0.01%
+159
New +$6.74K
ABG icon
436
Asbury Automotive
ABG
$4.31B
$6K ﹤0.01%
+106
New +$6.62K
ALB icon
437
Albemarle
ALB
$13.9B
$6K ﹤0.01%
50
AMKR icon
438
Amkor Technology
AMKR
$12.4B
$6K ﹤0.01%
+682
New +$7.3K
BDX icon
439
Becton Dickinson
BDX
$45.6B
$6K ﹤0.01%
31
BMA icon
440
Banco Macro
BMA
$5.88B
$6K ﹤0.01%
+54
New +$6.33K
CAH icon
441
Cardinal Health
CAH
$53.9B
$6K ﹤0.01%
100
CTAS icon
442
Cintas
CTAS
$81.9B
$6K ﹤0.01%
+164
New +$6.24K
EVN
443
Eaton Vance Municipal Income Trust
EVN
$414M
$6K ﹤0.01%
500
GBX icon
444
The Greenbrier Companies
GBX
$1.52B
$6K ﹤0.01%
+121
New +$6.07K
CBIO
445
Crescent Biopharma
CBIO
$537M
$6K ﹤0.01%
+4
New +$5.29K
B
446
Barrick Mining
B
$61.5B
$6K ﹤0.01%
421
+21
+5% +$310
HDV
447
iShares Core High Dividend ETF
HDV
$14.5B
$6K ﹤0.01%
+350
New +$6.12K
HUBB icon
448
Hubbell
HUBB
$25B
$6K ﹤0.01%
+50
New +$6.24K
ITGR icon
449
Integer Holdings
ITGR
$4.12B
$6K ﹤0.01%
+150
New +$7.31K
IYT icon
450
iShares US Transportation ETF
IYT
$2.26B
$6K ﹤0.01%
+128
New +$5.77K

Similar funds

Royal Fund Management's Q4 2017 Portfolio in Review

As of Q4 2017, Royal Fund Management held 719 positions worth $279M, up 11% from $251M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Royal Fund Management deployed $13.4M of net new capital in Q4 2017, opening 225 new positions and adding to 172 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 ETF: 47,863 shares worth $1.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, up from 15% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Merck, an estimated $6.79M trimmed.

  • Royal Fund Management's largest Q4 2017 buy was State Street SPDR Portfolio S&P 500 ETF: 47,863 shares worth $1.5M.
  • Royal Fund Management added most to IBM in Q4 2017, an estimated $7.47M increase.
  • Royal Fund Management's biggest Q4 2017 reduction was Merck, cutting an estimated $6.79M.
  • Royal Fund Management fully exited iShares US Real Estate ETF in Q4 2017, selling an estimated $104K.
  • Royal Fund Management's ten largest holdings make up 34% of its $279M portfolio in Q4 2017.
  • Royal Fund Management opened 225 new positions and closed 44 in Q4 2017.
  • Royal Fund Management's portfolio value rose 11% quarter-over-quarter to $279M.

Based on Royal Fund Management's 13F filing for Q4 2017, filed 7 May 2020.